IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bellevue Group AG

Q3 2023 Holdings

Filed 2023-11-14 | 196 holdings | $6.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Neurocrine Biosciences Inc(NBIX)COM64125C109$290.6M2,583,5504.7%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$348.7M1,002,7355.6%
Ionis Pharmaceuticals Inc(IONS)COM462222100$418.8M9,233,7006.7%
Argenx SE(ARGX)SPONSORED ADR04016X101$448.1M911,5307.2%
PreviousPage 4 of 4